Ocorrência de falso positivo em testes com peptídeos sintéticos para pesquisa de anticorpos contra o vírus da imunodeficiência humana tipo 2 (HIV-2) em pacientes brasileiros infectados pelo vírus da imunodeficiência humana tipo 1 (HIV-1)

Machado, Alcyone Artioli; Hirsch, Ivan; Figueiredo, José Fernando C.; Martinez, Roberto; Freitas-Silva, Gilson de; Chermann, Jean-Claude; Covas, Dimas Tadeu

doi:10.1590/S0037-86821996000600016

COMUNICAÇÃO

Ocorrência de falso positivo em testes com peptídeos sintéticos para pesquisa de anticorpos contra o vírus da imunodeficiência humana tipo 2 (HIV-2) em pacientes brasileiros infectados pelo vírus da imunodeficiência humana tipo 1 (HIV-1)

Alcyone Artioli Machado; Ivan Hirsch; José Fernando C. Figueiredo; Roberto Martinez; Gilson de Freitas-Silva; Jean-Claude Chermann; Dimas Tadeu Covas

^{Endereço para correspondência} Endereço para correspondência: Dr a Alcyone Axtioli Machado. Departamento de Clínica Médica/FMRP/USP. Av. Bandeirantes 3900 14049-900 Ribeirão Preto, SP.

Texto completo disponível apenas em PDF.

Full text available only in PDF format.

REFERÊNCIAS BIBLIOGRÁFICAS

1. Barré-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Vezinet-Brun F, Rouzioux C, Rozenbaun W, Montagnier L. Isoiation of a T-lvmphotropic retrovírus from a patient at risk for acquired immunodeficiency (AIDS). Science 220:868-871, 1983.

2. Cambridge Biothec Corporation. Recombigen HIV-l/HIV-2 rapid test device. Irlanda (catalog 6052), 1991.

3. Centers for Disease Control. AIDS due to HIV-2 infection- New Jersey Morbitity and Mortality Weekly Report 37:33-35 ,1988.

4. Clavel F, Guetard D, Brun-Vezinet F, Chamaret S, Rey M, Santos-Ferreira MO, Laurent AG, Dauguet C, Katlama C, Rouzioux C, Klatzman D, Champalimaud JL, Montagnier L. Isolation of a new retrovirus from West African patients with AIDS. Science 233:343-346 ,1986.

5. Cortes E, Detels R,Aboulafia D Li XL, MoudgilT, Alam M, Bonecker C, Gonzaga A, Oyafuso L.Tondo M, Boite C, Hammershlak N, Capitani C, Slamon DJ, Ho DD. HIV-1,HIV-2, and HTLV-1 infection in high-risk groups in Brazil. New England Journal of Medicine 320:953-958 ,1989.

6. Danuta Pieniazek JMF Ferreira JA, Krebs JW, Owen SM, Sion FS, Filho CFR, Sereno AB, Morais de Sä CA, Weniger BG, Heyward WL, Ou C-Y, Pieniazek NJ, Schochetman G, Rayfield MA. Identification of mixed HIV-l/HIV-2 Infections in Brazil by polymerase chain reaction. Acquired Immune Deficiency Syndrome 5:1293-1299, 1991.

7. DIAGNOSTICS PASTEUR . Pepti-Lav 1-2. France (code 72253),1989.

8. Essex M, Kanki PJ. Human Immunodeficiency Virus type 2 (HIV-2). In: Broder S, MeriganJrTC, Bolognesi D (eds) Textbook of AIDS Medicine, lnd edition, Baltimore, Maryland, USA, p. 873-886, 1994.

9. George JR, Ou CY, Parekh B, Brattegaard KB, Brown V, Boateng E, De Cock KM. Prevalence of HIV-1 and HIV-2 mixed infections in Cote d'Ivoire. Lancet 340:337-339 ,1992.

10. Gnann Jr JW, McCormick JB, Mitchell SW, Nelson JA, Oldstone MB. Synthetic peptide immunoassay distinguishes HIV type 1 and type 2 infections. Science 237:1346-1349,1987.

11. Granato C, Castelo A, Waldman EA, Gerbi L, Zamarioli L, Lorenco R, Johnson Jr W. Occurence of HIV-1 and HTV-2 in Brazil. Journal of Acquired Immunodeficiency Syndrome 5:531-532 ,1992.

12. Hendry RM, Parks DE, Mello DLAC, Quinnan GV, Galväo-Castro B. Lack of evidence for HIV-2 infection among at-risk individuals in Brazil. Journal of Acquired Immunodeficiency Syndrome 4:623-627,1991.

13. Horsburgh Jr CR, Holmberg SD. The global distribution of human immunodeficiency vírus type-2 (HIV-2) infection.Transfusion 28 -.192-195, 1988.

14. Ministério da Saúde. Programa Nacional de Doenças Sexualmente Transmissíveis/AIDS. Boletim Epidemiológico-AIDS VIII:1-16,1995.

15. O'Brien TR, Polon C, Schable CA, VanDevanter N, Rayfield MA, Wallace D, Stuart A, Holmberg SD. HIV-2 infection in an American .Acquired Immune Deficiency Syndrome, 5: 85-88, 1991.

16. O'Brien TR, George R, Holmberg SD. Human immunodeficiency virus type 2 infection in the United States. Journal of the American Medical Associaton 267:2775-2779 ,1992.

17. Peeters M, Gershy-Damet G-M,Fransen M, Koffi K, Coulibaly M, Delaporte E, Piot P, Van der Groen G. Virological and polymerase chain reaction studies of HIV-l/HIV-2 dual infection in Cote d'Ivoire. Lancet 340:339-340 ,1992.

18. Pfiitzner A, Dietrich U, Eichel U, Briesen H, Brede HD,Maniar JK, Rubsamen-Waigmann H. HIV-1 and HIV-2 infections in a high-risk popuation in Bombay'; India.Evidence for the spread of HIV-2 and presence of a divergent HIV-1 subtype. Journal of Acquired Immune Deficiency Syndromes 5:972-977,1992. 19. Soriano Y Gutierrez JL, Aguilera A, Gonzalez A, Bernal A, HIV-2 Spanish Study Group HIV-2 infection in Spain:report of the first 34 cases. Acquired Immune Deficiency Syndrome 6:222- 223,1992.

Recebido para publicação em 21/11/95.

1. Barré-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Vezinet-Brun F, Rouzioux C, Rozenbaun W, Montagnier L. Isoiation of a T-lvmphotropic retrovírus from a patient at risk for acquired immunodeficiency (AIDS). Science 220:868-871, 1983.
2. Cambridge Biothec Corporation. Recombigen HIV-l/HIV-2 rapid test device. Irlanda (catalog 6052), 1991.
3. Centers for Disease Control. AIDS due to HIV-2 infection- New Jersey Morbitity and Mortality Weekly Report 37:33-35 ,1988.
4. Clavel F, Guetard D, Brun-Vezinet F, Chamaret S, Rey M, Santos-Ferreira MO, Laurent AG, Dauguet C, Katlama C, Rouzioux C, Klatzman D, Champalimaud JL, Montagnier L. Isolation of a new retrovirus from West African patients with AIDS. Science 233:343-346 ,1986.
5. Cortes E, Detels R,Aboulafia D Li XL, MoudgilT, Alam M, Bonecker C, Gonzaga A, Oyafuso L.Tondo M, Boite C, Hammershlak N, Capitani C, Slamon DJ, Ho DD. HIV-1,HIV-2, and HTLV-1 infection in high-risk groups in Brazil. New England Journal of Medicine 320:953-958 ,1989.
6. Danuta Pieniazek JMF Ferreira JA, Krebs JW, Owen SM, Sion FS, Filho CFR, Sereno AB, Morais de Sä CA, Weniger BG, Heyward WL, Ou C-Y, Pieniazek NJ, Schochetman G, Rayfield MA. Identification of mixed HIV-l/HIV-2 Infections in Brazil by polymerase chain reaction. Acquired Immune Deficiency Syndrome 5:1293-1299, 1991.
7. DIAGNOSTICS PASTEUR . Pepti-Lav 1-2. France (code 72253),1989.
8. Essex M, Kanki PJ. Human Immunodeficiency Virus type 2 (HIV-2). In: Broder S, MeriganJrTC, Bolognesi D (eds) Textbook of AIDS Medicine, lnd edition, Baltimore, Maryland, USA, p. 873-886, 1994.
9. George JR, Ou CY, Parekh B, Brattegaard KB, Brown V, Boateng E, De Cock KM. Prevalence of HIV-1 and HIV-2 mixed infections in Cote d'Ivoire. Lancet 340:337-339 ,1992.
10. Gnann Jr JW, McCormick JB, Mitchell SW, Nelson JA, Oldstone MB. Synthetic peptide immunoassay distinguishes HIV type 1 and type 2 infections. Science 237:1346-1349,1987.
11. Granato C, Castelo A, Waldman EA, Gerbi L, Zamarioli L, Lorenco R, Johnson Jr W. Occurence of HIV-1 and HTV-2 in Brazil. Journal of Acquired Immunodeficiency Syndrome 5:531-532 ,1992.
12. Hendry RM, Parks DE, Mello DLAC, Quinnan GV, Galväo-Castro B. Lack of evidence for HIV-2 infection among at-risk individuals in Brazil. Journal of Acquired Immunodeficiency Syndrome 4:623-627,1991.
13. Horsburgh Jr CR, Holmberg SD. The global distribution of human immunodeficiency vírus type-2 (HIV-2) infection.Transfusion 28 -.192-195, 1988.
14. Ministério da Saúde. Programa Nacional de Doenças Sexualmente Transmissíveis/AIDS. Boletim Epidemiológico-AIDS VIII:1-16,1995.
15. O'Brien TR, Polon C, Schable CA, VanDevanter N, Rayfield MA, Wallace D, Stuart A, Holmberg SD. HIV-2 infection in an American .Acquired Immune Deficiency Syndrome, 5: 85-88, 1991.
16. O'Brien TR, George R, Holmberg SD. Human immunodeficiency virus type 2 infection in the United States. Journal of the American Medical Associaton 267:2775-2779 ,1992.
17. Peeters M, Gershy-Damet G-M,Fransen M, Koffi K, Coulibaly M, Delaporte E, Piot P, Van der Groen G. Virological and polymerase chain reaction studies of HIV-l/HIV-2 dual infection in Cote d'Ivoire. Lancet 340:339-340 ,1992.
18. Pfiitzner A, Dietrich U, Eichel U, Briesen H, Brede HD,Maniar JK, Rubsamen-Waigmann H. HIV-1 and HIV-2 infections in a high-risk popuation in Bombay'; India.Evidence for the spread of HIV-2 and presence of a divergent HIV-1 subtype. Journal of Acquired Immune Deficiency Syndromes 5:972-977,1992.
19. Soriano Y Gutierrez JL, Aguilera A, Gonzalez A, Bernal A, HIV-2 Spanish Study Group HIV-2 infection in Spain:report of the first 34 cases. Acquired Immune Deficiency Syndrome 6:222- 223,1992.

Endereço para correspondência:

Dr

^a Alcyone Axtioli Machado.

Departamento de Clínica Médica/FMRP/USP.

Av. Bandeirantes 3900

14049-900

Ribeirão Preto, SP.

Datas de Publicação

Publicação nesta coleção
04 Abr 2013
Data do Fascículo
Dez 1996

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

[1] 1. Barré-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Vezinet-Brun F, Rouzioux C, Rozenbaun W, Montagnier L. Isoiation of a T-lvmphotropic retrovírus from a patient at risk for acquired immunodeficiency (AIDS). Science 220:868-871, 1983.

[2] 2. Cambridge Biothec Corporation. Recombigen HIV-l/HIV-2 rapid test device. Irlanda (catalog 6052), 1991.

[3] 3. Centers for Disease Control. AIDS due to HIV-2 infection- New Jersey Morbitity and Mortality Weekly Report 37:33-35 ,1988.

[4] 4. Clavel F, Guetard D, Brun-Vezinet F, Chamaret S, Rey M, Santos-Ferreira MO, Laurent AG, Dauguet C, Katlama C, Rouzioux C, Klatzman D, Champalimaud JL, Montagnier L. Isolation of a new retrovirus from West African patients with AIDS. Science 233:343-346 ,1986.

[5] 5. Cortes E, Detels R,Aboulafia D Li XL, MoudgilT, Alam M, Bonecker C, Gonzaga A, Oyafuso L.Tondo M, Boite C, Hammershlak N, Capitani C, Slamon DJ, Ho DD. HIV-1,HIV-2, and HTLV-1 infection in high-risk groups in Brazil. New England Journal of Medicine 320:953-958 ,1989.

[6] 6. Danuta Pieniazek JMF Ferreira JA, Krebs JW, Owen SM, Sion FS, Filho CFR, Sereno AB, Morais de Sä CA, Weniger BG, Heyward WL, Ou C-Y, Pieniazek NJ, Schochetman G, Rayfield MA. Identification of mixed HIV-l/HIV-2 Infections in Brazil by polymerase chain reaction. Acquired Immune Deficiency Syndrome 5:1293-1299, 1991.

[7] 7. DIAGNOSTICS PASTEUR . Pepti-Lav 1-2. France (code 72253),1989.

[8] 8. Essex M, Kanki PJ. Human Immunodeficiency Virus type 2 (HIV-2). In: Broder S, MeriganJrTC, Bolognesi D (eds) Textbook of AIDS Medicine, lnd edition, Baltimore, Maryland, USA, p. 873-886, 1994.

[9] 9. George JR, Ou CY, Parekh B, Brattegaard KB, Brown V, Boateng E, De Cock KM. Prevalence of HIV-1 and HIV-2 mixed infections in Cote d'Ivoire. Lancet 340:337-339 ,1992.

[10] 10. Gnann Jr JW, McCormick JB, Mitchell SW, Nelson JA, Oldstone MB. Synthetic peptide immunoassay distinguishes HIV type 1 and type 2 infections. Science 237:1346-1349,1987.

[11] 11. Granato C, Castelo A, Waldman EA, Gerbi L, Zamarioli L, Lorenco R, Johnson Jr W. Occurence of HIV-1 and HTV-2 in Brazil. Journal of Acquired Immunodeficiency Syndrome 5:531-532 ,1992.

[12] 12. Hendry RM, Parks DE, Mello DLAC, Quinnan GV, Galväo-Castro B. Lack of evidence for HIV-2 infection among at-risk individuals in Brazil. Journal of Acquired Immunodeficiency Syndrome 4:623-627,1991.

[13] 13. Horsburgh Jr CR, Holmberg SD. The global distribution of human immunodeficiency vírus type-2 (HIV-2) infection.Transfusion 28 -.192-195, 1988.

[14] 14. Ministério da Saúde. Programa Nacional de Doenças Sexualmente Transmissíveis/AIDS. Boletim Epidemiológico-AIDS VIII:1-16,1995.

[15] 15. O'Brien TR, Polon C, Schable CA, VanDevanter N, Rayfield MA, Wallace D, Stuart A, Holmberg SD. HIV-2 infection in an American .Acquired Immune Deficiency Syndrome, 5: 85-88, 1991.

[16] 16. O'Brien TR, George R, Holmberg SD. Human immunodeficiency virus type 2 infection in the United States. Journal of the American Medical Associaton 267:2775-2779 ,1992.

[17] 17. Peeters M, Gershy-Damet G-M,Fransen M, Koffi K, Coulibaly M, Delaporte E, Piot P, Van der Groen G. Virological and polymerase chain reaction studies of HIV-l/HIV-2 dual infection in Cote d'Ivoire. Lancet 340:339-340 ,1992.

[18] 18. Pfiitzner A, Dietrich U, Eichel U, Briesen H, Brede HD,Maniar JK, Rubsamen-Waigmann H. HIV-1 and HIV-2 infections in a high-risk popuation in Bombay'; India.Evidence for the spread of HIV-2 and presence of a divergent HIV-1 subtype. Journal of Acquired Immune Deficiency Syndromes 5:972-977,1992.

[19] 19. Soriano Y Gutierrez JL, Aguilera A, Gonzalez A, Bernal A, HIV-2 Spanish Study Group HIV-2 infection in Spain:report of the first 34 cases. Acquired Immune Deficiency Syndrome 6:222- 223,1992.

Brasil

Brasil

Ocorrência de falso positivo em testes com peptídeos sintéticos para pesquisa de anticorpos contra o vírus da imunodeficiência humana tipo 2 (HIV-2) em pacientes brasileiros infectados pelo vírus da imunodeficiência humana tipo 1 (HIV-1)

Endereço para correspondência:

Datas de Publicação